Petra Stefanic Anderluh

Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis.

Miha Kotnik, M. Kotnik, Petra Stefanic Anderluh, 2007, Current pharmaceutical design.

Recent advances in serine protease inhibitors as anticoagulant agents.

U. Urleb, Petra Stefanic Anderluh, A. Preželj, 2007, Current pharmaceutical design.

Utility of PFA-100 closure time vs. optical aggregometry in assessing the efficacy of platelet membrane glycoprotein IIb/IIIa antagonists in vitro.

M. Dolenc, D. Kikelj, M. Božič, 2007, Clinical chemistry and laboratory medicine.

Recent advances in the synthesis of 2H-1,4-benzoxazin-3-(4H)-ones and 3,4-dihydro-2H-1,4-benzoxazines

J. Ilaš, M. Dolenc, D. Kikelj, 2005 .

4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.

D. Turk, T. Šolmajer, M. Oblak, 2007, Journal of medicinal chemistry.

Synthesis of 8-Hydroxyimidazo[1,2-a]pyridine-2-carboxylic Acid and Its Derivatives

A. Meden, Uroš Grošelj, M. Oblak, 2008 .

Azaphenylalanine-based serine protease inhibitors induce caspase-mediated apoptosis.

Tina Batista Napotnik, I. Mlinarič-Raščan, A. Zega, 2009, European journal of pharmacology.

Recent Advances in the Synthesis of 2H‐1,4‐Benzoxazin‐3‐(4H)‐ones and 3,4‐Dihydro‐2H‐1,4‐benzoxazines

J. Ilaš, M. Dolenc, D. Kikelj, 2005 .